Skip to contentE
Enveric Biosciences, Inc.
E
ENVBEnveric Biosciences, Inc. Q1 2018 · 10-Q
Revenue$11.06M$11.06M−10.4% vs Q1 2017 Net Income-$1.57M-$1.57MN/M vs Q1 2017 EPS Diluted-$0.11-$0.11N/M vs Q1 2017 Gross Profit$2,342,885−29.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
Operating Cash Flow-$459,564N/M Margins · derivedGross margin21.2%−5.6 pt vs Q1 2017
Operating margin-12.4%−7.2 pt vs Q1 2017
Net margin-14.2%−4.3 pt vs Q1 2017
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end